Report Detail
Global CRISPR & Cas Genes Market Size, Status and Forecast 2020-2026
- RnM4158497 |
- 25 August, 2020 |
- Global |
- 132 Pages |
- QYResearch |
- Other
CRISPR & Cas Genes market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global CRISPR & Cas Genes market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Market segment by Type, the product can be split into
Vector-based Cas
DNA-free Cas
Cell Line Engineering
Market segment by Application, split into
Biotechnology and Pharmaceutical Companies
Academics and Government Research Institutes
Contract Research Organizations (CROs)
Based on regional and country-level analysis, the CRISPR & Cas Genes market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global CRISPR & Cas Genes market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
CRISPR Therapeutics
AstraZeneca
Addgene
Caribou Biosciences, Inc.
Cellectis
Editas Medicine, Inc.
Egenesis
F. Hoffmann-La Roche Ltd.
Horizon Discovery Group Plc
Genscrip
Danaher Corporation
Intellia Therapeutics, Inc.
Lonza
Merck KGaA
New England BioLabs
Takara Bio, Inc.
Synthego
Mammoth Biosciences
Inscripta, Inc.
1 Report Overview
- 1.1 Study Scope
- 1.2 Market Analysis by Type
- 1.2.1 Global CRISPR & Cas Genes Market Size Growth Rate by Type: 2020 VS 2026
- 1.2.2 Vector-based Cas
- 1.2.3 DNA-free Cas
- 1.2.4 Cell Line Engineering
- 1.3 Market by Application
- 1.3.1 Global CRISPR & Cas Genes Market Share by Application: 2020 VS 2026
- 1.3.2 Biotechnology and Pharmaceutical Companies
- 1.3.3 Academics and Government Research Institutes
- 1.3.4 Contract Research Organizations (CROs)
- 1.4 Study Objectives
- 1.5 Years Considered
2 Global Growth Trends
- 2.1 Global CRISPR & Cas Genes Market Perspective (2015-2026)
- 2.2 Global CRISPR & Cas Genes Growth Trends by Regions
- 2.2.1 CRISPR & Cas Genes Market Size by Regions: 2015 VS 2020 VS 2026
- 2.2.2 CRISPR & Cas Genes Historic Market Share by Regions (2015-2020)
- 2.2.3 CRISPR & Cas Genes Forecasted Market Size by Regions (2021-2026)
- 2.3 Industry Trends and Growth Strategy
- 2.3.1 Market Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Challenges
- 2.3.4 Market Restraints
3 Competition Landscape by Key Players
- 3.1 Global Top CRISPR & Cas Genes Players by Market Size
- 3.1.1 Global Top CRISPR & Cas Genes Players by Revenue (2015-2020)
- 3.1.2 Global CRISPR & Cas Genes Revenue Market Share by Players (2015-2020)
- 3.2 Global CRISPR & Cas Genes Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Players Covered: Ranking by CRISPR & Cas Genes Revenue
- 3.4 Global CRISPR & Cas Genes Market Concentration Ratio
- 3.4.1 Global CRISPR & Cas Genes Market Concentration Ratio (CR5 and HHI)
- 3.4.2 Global Top 10 and Top 5 Companies by CRISPR & Cas Genes Revenue in 2019
- 3.5 Key Players CRISPR & Cas Genes Area Served
- 3.6 Key Players CRISPR & Cas Genes Product Solution and Service
- 3.7 Date of Enter into CRISPR & Cas Genes Market
- 3.8 Mergers & Acquisitions, Expansion Plans
4 CRISPR & Cas Genes Breakdown Data by Type (2015-2026)
- 4.1 Global CRISPR & Cas Genes Historic Market Size by Type (2015-2020)
- 4.2 Global CRISPR & Cas Genes Forecasted Market Size by Type (2021-2026)
5 CRISPR & Cas Genes Breakdown Data by Application (2015-2026)
- 5.1 Global CRISPR & Cas Genes Historic Market Size by Application (2015-2020)
- 5.2 Global CRISPR & Cas Genes Forecasted Market Size by Application (2021-2026)
6 North America
- 6.1 North America CRISPR & Cas Genes Market Size (2015-2026)
- 6.2 North America CRISPR & Cas Genes Market Size by Type (2015-2020)
- 6.3 North America CRISPR & Cas Genes Market Size by Application (2015-2020)
- 6.4 North America CRISPR & Cas Genes Market Size by Country (2015-2020)
- 6.4.1 United States
- 6.4.2 Canada
7 Europe
- 7.1 Europe CRISPR & Cas Genes Market Size (2015-2026)
- 7.2 Europe CRISPR & Cas Genes Market Size by Type (2015-2020)
- 7.3 Europe CRISPR & Cas Genes Market Size by Application (2015-2020)
- 7.4 Europe CRISPR & Cas Genes Market Size by Country (2015-2020)
- 7.4.1 Germany
- 7.4.2 France
- 7.4.3 U.K.
- 7.4.4 Italy
- 7.4.5 Russia
- 7.4.6 Nordic
- 7.4.7 Rest of Europe
8 China
- 8.1 China CRISPR & Cas Genes Market Size (2015-2026)
- 8.2 China CRISPR & Cas Genes Market Size by Type (2015-2020)
- 8.3 China CRISPR & Cas Genes Market Size by Application (2015-2020)
- 8.4 China CRISPR & Cas Genes Market Size by Region (2015-2020)
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 South Korea
- 8.4.4 Southeast Asia
- 8.4.5 India
- 8.4.6 Australia
- 8.4.7 Rest of Asia-Pacific
9 Japan
- 9.1 Japan CRISPR & Cas Genes Market Size (2015-2026)
- 9.2 Japan CRISPR & Cas Genes Market Size by Type (2015-2020)
- 9.3 Japan CRISPR & Cas Genes Market Size by Application (2015-2020)
- 9.4 Japan CRISPR & Cas Genes Market Size by Country (2015-2020)
- 9.4.1 Mexico
- 9.4.2 Brazil
10 Southeast Asia
- 10.1 Southeast Asia CRISPR & Cas Genes Market Size (2015-2026)
- 10.2 Southeast Asia CRISPR & Cas Genes Market Size by Type (2015-2020)
- 10.3 Southeast Asia CRISPR & Cas Genes Market Size by Application (2015-2020)
- 10.4 Southeast Asia CRISPR & Cas Genes Market Size by Country (2015-2020)
- 10.4.1 Turkey
- 10.4.2 Saudi Arabia
- 10.4.3 UAE
- 10.4.4 Rest of Middle East & Africa
11Key Players Profiles
- 11.1 CRISPR Therapeutics
- 11.1.1 CRISPR Therapeutics Company Details
- 11.1.2 CRISPR Therapeutics Business Overview
- 11.1.3 CRISPR Therapeutics CRISPR & Cas Genes Introduction
- 11.1.4 CRISPR Therapeutics Revenue in CRISPR & Cas Genes Business (2015-2020))
- 11.1.5 CRISPR Therapeutics Recent Development
- 11.2 AstraZeneca
- 11.2.1 AstraZeneca Company Details
- 11.2.2 AstraZeneca Business Overview
- 11.2.3 AstraZeneca CRISPR & Cas Genes Introduction
- 11.2.4 AstraZeneca Revenue in CRISPR & Cas Genes Business (2015-2020)
- 11.2.5 AstraZeneca Recent Development
- 11.3 Addgene
- 11.3.1 Addgene Company Details
- 11.3.2 Addgene Business Overview
- 11.3.3 Addgene CRISPR & Cas Genes Introduction
- 11.3.4 Addgene Revenue in CRISPR & Cas Genes Business (2015-2020)
- 11.3.5 Addgene Recent Development
- 11.4 Caribou Biosciences, Inc.
- 11.4.1 Caribou Biosciences, Inc. Company Details
- 11.4.2 Caribou Biosciences, Inc. Business Overview
- 11.4.3 Caribou Biosciences, Inc. CRISPR & Cas Genes Introduction
- 11.4.4 Caribou Biosciences, Inc. Revenue in CRISPR & Cas Genes Business (2015-2020)
- 11.4.5 Caribou Biosciences, Inc. Recent Development
- 11.5 Cellectis
- 11.5.1 Cellectis Company Details
- 11.5.2 Cellectis Business Overview
- 11.5.3 Cellectis CRISPR & Cas Genes Introduction
- 11.5.4 Cellectis Revenue in CRISPR & Cas Genes Business (2015-2020)
- 11.5.5 Cellectis Recent Development
- 11.6 Editas Medicine, Inc.
- 11.6.1 Editas Medicine, Inc. Company Details
- 11.6.2 Editas Medicine, Inc. Business Overview
- 11.6.3 Editas Medicine, Inc. CRISPR & Cas Genes Introduction
- 11.6.4 Editas Medicine, Inc. Revenue in CRISPR & Cas Genes Business (2015-2020)
- 11.6.5 Editas Medicine, Inc. Recent Development
- 11.7 Egenesis
- 11.7.1 Egenesis Company Details
- 11.7.2 Egenesis Business Overview
- 11.7.3 Egenesis CRISPR & Cas Genes Introduction
- 11.7.4 Egenesis Revenue in CRISPR & Cas Genes Business (2015-2020)
- 11.7.5 Egenesis Recent Development
- 11.8 F. Hoffmann-La Roche Ltd.
- 11.8.1 F. Hoffmann-La Roche Ltd. Company Details
- 11.8.2 F. Hoffmann-La Roche Ltd. Business Overview
- 11.8.3 F. Hoffmann-La Roche Ltd. CRISPR & Cas Genes Introduction
- 11.8.4 F. Hoffmann-La Roche Ltd. Revenue in CRISPR & Cas Genes Business (2015-2020)
- 11.8.5 F. Hoffmann-La Roche Ltd. Recent Development
- 11.9 Horizon Discovery Group Plc
- 11.9.1 Horizon Discovery Group Plc Company Details
- 11.9.2 Horizon Discovery Group Plc Business Overview
- 11.9.3 Horizon Discovery Group Plc CRISPR & Cas Genes Introduction
- 11.9.4 Horizon Discovery Group Plc Revenue in CRISPR & Cas Genes Business (2015-2020)
- 11.9.5 Horizon Discovery Group Plc Recent Development
- 11.10 Genscrip
- 11.10.1 Genscrip Company Details
- 11.10.2 Genscrip Business Overview
- 11.10.3 Genscrip CRISPR & Cas Genes Introduction
- 11.10.4 Genscrip Revenue in CRISPR & Cas Genes Business (2015-2020)
- 11.10.5 Genscrip Recent Development
- 11.11 Danaher Corporation
- 10.11.1 Danaher Corporation Company Details
- 10.11.2 Danaher Corporation Business Overview
- 10.11.3 Danaher Corporation CRISPR & Cas Genes Introduction
- 10.11.4 Danaher Corporation Revenue in CRISPR & Cas Genes Business (2015-2020)
- 10.11.5 Danaher Corporation Recent Development
- 11.12 Intellia Therapeutics, Inc.
- 10.12.1 Intellia Therapeutics, Inc. Company Details
- 10.12.2 Intellia Therapeutics, Inc. Business Overview
- 10.12.3 Intellia Therapeutics, Inc. CRISPR & Cas Genes Introduction
- 10.12.4 Intellia Therapeutics, Inc. Revenue in CRISPR & Cas Genes Business (2015-2020)
- 10.12.5 Intellia Therapeutics, Inc. Recent Development
- 11.13 Lonza
- 10.13.1 Lonza Company Details
- 10.13.2 Lonza Business Overview
- 10.13.3 Lonza CRISPR & Cas Genes Introduction
- 10.13.4 Lonza Revenue in CRISPR & Cas Genes Business (2015-2020)
- 10.13.5 Lonza Recent Development
- 11.14 Merck KGaA
- 10.14.1 Merck KGaA Company Details
- 10.14.2 Merck KGaA Business Overview
- 10.14.3 Merck KGaA CRISPR & Cas Genes Introduction
- 10.14.4 Merck KGaA Revenue in CRISPR & Cas Genes Business (2015-2020)
- 10.14.5 Merck KGaA Recent Development
- 11.15 New England BioLabs
- 10.15.1 New England BioLabs Company Details
- 10.15.2 New England BioLabs Business Overview
- 10.15.3 New England BioLabs CRISPR & Cas Genes Introduction
- 10.15.4 New England BioLabs Revenue in CRISPR & Cas Genes Business (2015-2020)
- 10.15.5 New England BioLabs Recent Development
- 11.16 Takara Bio, Inc.
- 10.16.1 Takara Bio, Inc. Company Details
- 10.16.2 Takara Bio, Inc. Business Overview
- 10.16.3 Takara Bio, Inc. CRISPR & Cas Genes Introduction
- 10.16.4 Takara Bio, Inc. Revenue in CRISPR & Cas Genes Business (2015-2020)
- 10.16.5 Takara Bio, Inc. Recent Development
- 11.17 Synthego
- 10.17.1 Synthego Company Details
- 10.17.2 Synthego Business Overview
- 10.17.3 Synthego CRISPR & Cas Genes Introduction
- 10.17.4 Synthego Revenue in CRISPR & Cas Genes Business (2015-2020)
- 10.17.5 Synthego Recent Development
- 11.18 Mammoth Biosciences
- 10.18.1 Mammoth Biosciences Company Details
- 10.18.2 Mammoth Biosciences Business Overview
- 10.18.3 Mammoth Biosciences CRISPR & Cas Genes Introduction
- 10.18.4 Mammoth Biosciences Revenue in CRISPR & Cas Genes Business (2015-2020)
- 10.18.5 Mammoth Biosciences Recent Development
- 11.19 Inscripta, Inc.
- 10.19.1 Inscripta, Inc. Company Details
- 10.19.2 Inscripta, Inc. Business Overview
- 10.19.3 Inscripta, Inc. CRISPR & Cas Genes Introduction
- 10.19.4 Inscripta, Inc. Revenue in CRISPR & Cas Genes Business (2015-2020)
- 10.19.5 Inscripta, Inc. Recent Development
- 11.20 Cibus
- 10.20.1 Cibus Company Details
- 10.20.2 Cibus Business Overview
- 10.20.3 Cibus CRISPR & Cas Genes Introduction
- 10.20.4 Cibus Revenue in CRISPR & Cas Genes Business (2015-2020)
- 10.20.5 Cibus Recent Development
12Analyst's Viewpoints/Conclusions
13Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.2 Data Source
- 13.2 Disclaimer
Summary:
Get latest Market Research Reports on CRISPR & Cas Genes. Industry analysis & Market Report on CRISPR & Cas Genes is a syndicated market report, published as Global CRISPR & Cas Genes Market Size, Status and Forecast 2020-2026. It is complete Research Study and Industry Analysis of CRISPR & Cas Genes market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
